Drugs / LAPULEUCEL-T
LAPULEUCEL-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01353222 | Jun 2011 → Jul 2015 | urothelial carcinoma | Dendreon | Terminated | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAPULEUCEL-T | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108615 ↗ |
| Known as | APC-8024 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108615 ↗ |
| Known as | DN24-02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01353222 ↗ |
| Modality | Cell therapy | “autologous cellular immunotherapy product” NCT01353222 ↗ |